STVN — Stevanato Group S.p.A.
—
NYSE ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1849853 ·
Italy
Last close
$17.06
Market Cap
$848.05M
52W High
$19.70
52W Low
$12.84
ADV30
401,237
Next earnings
2026-08-04
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 273,574,000 | 75,178,000 | 38,737,000 | 28,029,000 | 2,583,821,000 | 111,670,000 | 1,052,995,000 |
| Dec 2025 | 346,482,000 | 106,899,000 | 70,084,000 | 47,555,000 | 2,543,974,000 | 130,603,000 | 1,057,453,000 |
| Sep 2025 | 303,167,000 | 88,500,000 | 52,721,000 | 36,064,000 | 2,414,007,000 | 113,333,000 | 976,721,000 |
| Jun 2025 | 280,000,000 | 78,600,000 | 41,400,000 | 29,700,000 | 2,351,100,000 | 94,200,000 | 953,200,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$261,728,000
Investing CF
$-272,608,000
Financing CF
$32,881,000
CapEx
$-273,964,000
Dividends Paid
$-14,457,000
Buybacks
—
EPS Diluted TTM
$0.51
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$1,019,614,000
Inventory
$294,360,000
Receivables
$506,659,000
ST Investments
$1,064,000
EBIT TTM
$209,266,000
Pretax Income TTM
$193,228,000
Interest Exp TTM
$16,038,000
Analysts
8
Yahoo Snapshot (yfinance, live)
Total Revenue
$1,203,260,032
EBITDA
$288,579,008
Free Cash Flow
$-57,059,124
Enterprise Value
$4,845,635,072
Total Cash
$112,276,000
Total Debt
$450,584,000
Shares Out
49,709,718
Trailing EPS
$0.59
Book Value
$6.47
ROE
9.6%
ROA
5.3%
Div Yield
0.37%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 1,186,282,000 | 198,801,000 | 139,839,000 | 2,543,974,000 | 1,057,453,000 | — | 286,077,000 |
| Dec 2024 | 1,104,036,000 | 161,142,000 | 117,778,000 | 2,328,819,000 | 924,434,000 | — | 155,776,000 |
| Dec 2023 | 1,085,354,000 | 200,720,000 | 145,631,000 | 2,071,577,000 | 938,931,000 | — | 105,210,000 |
| Dec 2022 | 983,680,000 | 192,431,000 | 142,849,000 | 1,659,698,000 | 663,788,000 | — | 103,312,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$0.84
Max Pain — expiry 2026-09-18 (volume-derived — Yahoo OI feed degraded)
max pain strike: $17.50 · spot: $17.06 · call volume: 9 · put volume: 6
Expected Move to 2026-09-18:
±$4.45
(26.08%) —
implied range
$12.61 –
$21.51
· ATM straddle on $17.50 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| DRTS | Alpha Tau Medical Ltd. | $868.03M | $9.61 | — |
| INMD | InMode Ltd. | $812.40M | $13.36 | — |
| AVR | Anteris Technologies Global Corp. | $924.75M | $9.50 | — |
| CNMD | CONMED Corp | $966.81M | $32.11 | — |
| AORT | ARTIVION, INC. | $1.03B | $21.20 | — |
News headlines (Yahoo Finance, 1h cache)
Stevanato Group (STVN) Stock Valuation Check After Recent Share Price Weakness
2026-06-14 10:10 · Yahoo
Is Stevanato Group S.p.A. (STVN) A Good Stock To Buy Now?
2026-06-11 17:18 · Yahoo
2 Dirt Cheap Healthcare Stocks to Buy With $1,000 Right Now
2026-06-09 15:05 · Yahoo
Stevanato Group Introduces Deora™, a Pen Injector for Subcutaneous Delivery in Diabetes and Weight Management
2026-06-08 10:30 · Yahoo
Stevanato Group Announces Results of Ordinary and Extraordinary Shareholders’ Meeting
2026-06-03 21:45 · Yahoo
Implied Volatility Surging for Stevanato Stock Options
2026-06-03 15:50 · Yahoo
Earnings Beat: Stevanato Group S.p.A. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
2026-05-09 14:02 · Yahoo
Stevanato (STVN) Q1 2026 Earnings Transcript
2026-05-08 15:58 · Yahoo
Stevanato Group S.p.A. Q1 2026 Earnings Call Summary
2026-05-08 12:30 · Yahoo
Stevanato Group (STVN) Q1 Earnings and Revenues Beat Estimates
2026-05-07 11:45 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.